Cystatin c and Beta 2 Microglobulin in Thalassemic Children.

NCT03881917 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2019-03-20

No results posted yet for this study

Summary

Beta thalassemia has many complications on many systems as the renal system.So early detection of renal impairment is required in those children to decrease complications of this nephropathy.

Conditions

  • Blood Disease

Interventions

DIAGNOSTIC_TEST

Cystatin c and beta 2 microglobulin kits

Kits for measurement concentration

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2020-11-01
Completion
2021-03-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03881917 on ClinicalTrials.gov